Log in or Sign up for Free to view tailored content for your specialty!
Hormone Therapy News
Testosterone therapy plus very low calorie diet prevents lean mass loss in men
BOSTON — Healthy men with obesity and low testosterone randomly assigned testosterone therapy combined with a very low calorie diet maintained their muscle mass while losing body fat, whereas men assigned placebo lost both lean and fat mass, according to study findings presented here.
Aromatase inhibitor, GH combination increases growth in boys with idiopathic short stature
BOSTON — In adolescent boys with idiopathic short stature, combination therapy with growth hormone and aromatase inhibitors was more effective in increasing adult height potential than growth hormone or aromatase inhibitors alone through 24 months.
Log in or Sign up for Free to view tailored content for your specialty!
Bone, body composition altered in Turner syndrome despite treatment
BOSTON — Among women with Turner syndrome, bone and body composition alterations are evident even when growth hormone and estrogen therapies are used.
VIDEO: Long-acting GnRH analogues generally safe, effective with long-term use
BOSTON — In this video exclusive, Erica A. Eugster, MD, professor of pediatrics and director of the section of pediatric endocrinology at Indiana University School of Medicine in Indianapolis, discusses long-acting gonadotropin-releasing hormone analogues used for the treatment of central precocious puberty.
Aromatase inhibition decreases insulin resistance in healthy men
Healthy men randomly assigned the aromatase-inhibiting drug Arimidex saw reduced insulin resistance at 6 weeks vs. men assigned placebo, according to recent findings.
Obesity, oral contraceptive use linked to rare stroke risk
Women with obesity using oral contraceptives are at greater risk for cerebral venous thrombosis than normal-weight women not using oral contraceptives, according to study results.
Prepubertal children with GH deficiency face early CV risks
Prepubertal children with growth hormone deficiency already present with several cardiovascular risk markers, including abnormal lipid profiles, elevated inflammatory and oxidative stress markers, and reduced cardiac mass, according to a recent review.
Apolipoprotein C-III levels remain unaltered following leptin replacement in lipodystrophy
In patients with lipodystrophy, leptin replacement is not sufficient to affect elevated apolipoprotein C-III plasma levels.
No adverse metabolic changes seen in older adults discontinuing GH therapy
Discontinuing recombinant human growth hormone therapy in routine clinical practice does not cause significant metabolic changes in older adults, study findings show.
Estradiol aromatization mediates testosterone effects on prostate
Aromatization to estradiol mediates the tropic effects of testosterone on the prostate, according to study findings published in The Journal of Clinical Endocrinology & Metabolism.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read